Pacer Advisors’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,354
Closed -$128K 3942
2025
Q2
$128K Sell
1,354
-218
-14% -$23.9K ﹤0.01% 2178
2025
Q1
$187K Sell
1,572
-183
-10% -$24.9K ﹤0.01% 1788
2024
Q4
$231K Buy
1,755
+73
+4% +$8.96K ﹤0.01% 1881
2024
Q3
$218K Buy
1,682
+704
+72% +$82.8K ﹤0.01% 1841
2024
Q2
$84.9K Buy
978
+721
+281% +$75.5K ﹤0.01% 2542
2024
Q1
$28.2K Buy
257
+135
+111% +$13.6K ﹤0.01% 3373
2023
Q4
$12.8K Buy
122
+53
+77% +$5.17K ﹤0.01% 3361
2023
Q3
$7.25K Hold
69
﹤0.01% 2585
2023
Q2
$8.87K Buy
+69
New +$10.5K ﹤0.01% 3393

Other funds holding MLAB

Pacer Advisors's MLAB Position: Q3 2025 in Review

Pacer Advisors sold out of Mesa Laboratories (MLAB) in Q3 2025, closing a stake of 1,354 shares — an estimated $128K sold.

Pacer Advisors first reported a position in MLAB in Q2 2023 and held it in 9 quarters. The position peaked at $231K in Q4 2024. 141 funds tracked by Wall St. Rank hold MLAB as of Q3 2025.

  • Pacer Advisors reported no remaining Mesa Laboratories position as of Q3 2025 after selling out during the quarter.
  • Pacer Advisors sold 1,354 Mesa Laboratories shares in Q3 2025, an estimated $128K.
  • Pacer Advisors first reported a position in Mesa Laboratories in Q2 2023 and held it in 9 quarters.
  • Pacer Advisors's Mesa Laboratories position peaked at $231K in Q4 2024.
  • 141 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2025.

Based on Pacer Advisors's 13F filing for Q3 2025, filed 15 Oct 2025.